Industry focus: Healthcare and life sciences

Bignon Lebray

Bignon Lebray houses a broad offering known for handling unfair competition cases and data protection matters. In Lyon, Barbara Bertholet leads the team with her longstanding experience assisting a diverse client list of medical device and cosmetic manufacturers, and laboratories. Paris’ Caroline Cazaux often draws on her broad antitrust and competition expertise to advise on distribution issues surrounding healthcare and food products.

L'éditorial du Legal 500

Profil: bignonlebray.com

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

‘The team knows the health/biotech sector very well and knows how to adapt to the client's needs.’
‘We worked with Barbara Bertholet and Rachel Devidal who were very efficient.’
‘All members of the firm are experts and provide very good legal advice adapted to biotechs. The firm is very responsive to deadlines and very professional. The quality of interaction and discussions with this firm are above other competitors. The team is dynamic.’
‘Barbara Bertholet obviously has senior experience but also a rare human dimension that is very appreciated and which makes the difference in the relationship with the client (discussion, support, understanding).’

Clients clés

LYS Therapeutics

Points forts

Assisted with organising regular training sessions for members of a non-profit organisation, which includes CROs and investigator centres, to address questions on regulatory issues related to clinical trials (pharmaceuticals, medical devices, and IVDs).

Assisting a medical technology company specialising in innovative software solutions for the planning and treatment of neurovascular diseases, particularly aneurysms, with contracts involving its US subsidiary to manage data flows and protect intellectual property related to its software.

Assisting a French company that specialised in the production of food supplements, regarding the termination of its relationship with an influencer, mainly after the publication of a controversial position that may have a negative impact on its image.

Le Legal 500

FAQ

Lettres d'information

Contactez-nous